This application view consolidates identifiers, linked product and market authorization context, dossier structure, sequence history, and active authority obligations in one place. Regulatory teams use it to understand readiness and risk before publishing new sequences or responding to open questions. Cross-links to labeling and variations maintain lifecycle traceability for post-approval changes. Inspection readiness risk is calculated from overdue commitments, failed sequences, and unresolved high-risk correspondence for immediate action.

Application ID
APP-063
Application Number
PMDA-2022-0063
Procedure Type
NDS
Status
Pending
Linked Product
Market Authorization
Japan · PMDA
Dossier Structure View
DossierFormatVersionModulesModule BreakdownStatus
DOS-063NeeS8.3.75M1 (14), M2 (5), M3 (10), M4 (12), M5 (12)Submitted
Sequence Timeline
2022-02-03
0063 · Renewal
Status: completed. ACK: 2024-05-05.
2023-03-07
0163 · Annual Report
Status: overdue. ACK: pending.
2022-05-13
0263 · Labeling Update
Status: pending. ACK: pending.
2024-01-23
0363 · Type IB Variation
Status: pending. ACK: 2024-05-02.
Linked Labeling and Variations
Labeling ArtifactTypeVersionStatus
LBL-187PIL9.3Approved
LBL-188PIL17.3In Progress
LBL-189SmPC13.0In Progress
VariationTypeStatusSubmitted
PMDA-2022-0063-V063MajorDraft2023-01-17
PMDA-2022-0063-V163MajorActive2023-03-25
PMDA-2022-0063-V263Type IBIn Progress2023-09-20
PMDA-2022-0063-V363MajorActive2024-03-22
PMDA-2022-0063-V463Type IIApproved2023-01-16
Inspection Readiness Risk Panel
Risk Score: 3 · Overdue commitments: 1, failed/blocked sequences: 0, high-risk questions: 1.
Recommended next step: resolve outstanding questions and commitments before next publishing cycle to reduce inspection exposure.